Treatment of insulin-like growth factor deficiency with IGF-I: studies in humans.
Backeljauw
Philippe F
PF
Division of Endocrinology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229-3039, USA. philippe.backeljauw@cchmc.org
Chernausek
Steven D
SD
D004703:Endocrine System / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006130:Growth Disorders / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D020249:Hormone Replacement Therapy / Q000009:adverse effects / Q000379:methods; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology / Q000473:pathology; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000009:adverse effects / Q000627:therapeutic use*; D007334:Insulin-Like Growth Factor I / Q000009:adverse effects / Q000172:deficiency* / Q000627:therapeutic use*; D008107:Liver Diseases / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D008297:Male
D018972:Insulin-Like Growth Factor Binding Protein 3; D007334:Insulin-Like Growth Factor I